[1]
N. Lioufas, A. Street, P. C. de Crespigny, and S. G. Holt, “Monitoring the Effects of Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Switch for Tubulotoxicity in Highly Treatment-Experienced or in Very Sick Individuals Infected with HIV”, jrenhep, vol. 2, no. 2, pp. 1–5, Jun. 2018, doi: 10.15586/jrenhep.2018.33.